Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants.

Trial Profile

Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2014

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary) ; Poliovirus vaccine live oral
  • Indications Gastroenteritis; Poliomyelitis; Rotavirus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 19 Feb 2009 End date added, as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Results published in The Pediatric Infectious Disease Journal, according to 1127878.
    • 01 Oct 2008 Actual number of patients added as 730 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top